[Use of low molecular weight heparin in thromboembolic disease].
Uresandi Romero
F
F
D000005:Abdomen / Q000601:surgery; D000818:Animals; D002986:Clinical Trials as Topic; D004311:Double-Blind Method; D005260:Female; D006470:Hemorrhage / Q000139:chemically induced; D006495:Heparin, Low-Molecular-Weight / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006801:Humans; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D011247:Pregnancy; D013923:Thromboembolism / Q000188:drug therapy* / Q000517:prevention & control; D013924:Thrombophlebitis / Q000517:prevention & control
D006495:Heparin, Low-Molecular-Weight; C079002:Logiparin